rVV-740CTA vaccine (University Hospital Basel)

N/A

Report date: 2024/03/20 11:42:02

Base Information

Drug NamerVV-740CTA vaccine (University Hospital Basel)
Drug Alias NamerVV-740CTA
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionCD40 ligand stimulantsCluster of differentiation 80 stimulants
TargetsCD40 ligandCluster of differentiation 80
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Hospital Basel
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Hospital Basel
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A